Trial Profile
Descriptive Analysis of First-Cycle Prophylactic Use of G-CSF in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated With High Neutropenia Risk Chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- 24 Jul 2021 Status changed from active, no longer recruiting to completed.
- 05 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2016 New trial record